Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?
Ocular Therapeutix Ownership Summary
Ocular Therapeutix is owned by 90.91% institutional investors, 3.37% insiders, and 5.72% retail investors. Blackrock is the largest institutional shareholder, holding 8.73% of OCUL shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.68% of its assets in Ocular Therapeutix shares.
OCUL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Ocular Therapeutix | 90.91% | 3.37% | 5.72% |
Sector | Healthcare Stocks | 479.67% | 11.03% | -390.70% |
Industry | Biotech Stocks | 295.80% | 10.97% | -206.77% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 11.52M | 8.73% | $78.80M |
Deep track capital, lp | 14.29M | 8.28% | $132.65M |
Summer road | 13.89M | 8.05% | $128.88M |
Vr adviser | 12.76M | 7.39% | $118.44M |
Blackrock funding, inc. /de | 10.55M | 6.11% | $97.87M |
Vanguard group | 8.48M | 5.08% | $72.45M |
Avoro capital advisors | 7.40M | 4.29% | $68.67M |
Tcg crossover management | 5.32M | 3.08% | $49.36M |
State street | 3.92M | 2.97% | $26.82M |
Opaleye management | 4.34M | 2.60% | $37.08M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Summer road | 13.89M | 98.23% | $128.88M |
Acuta capital partners | 1.01M | 13.15% | $9.42M |
Vr adviser | 12.76M | 8.88% | $118.44M |
Opaleye management | 4.34M | 6.49% | $37.08M |
Tcg crossover management | 5.32M | 5.64% | $49.36M |
Rosalind advisors | 1.13M | 4.93% | $9.64M |
Deltec asset management | 2.79M | 4.62% | $25.94M |
Deep track capital, lp | 14.29M | 4.25% | $132.65M |
Octagon capital advisors lp | 2.42M | 3.41% | $20.71M |
Saturn v capital management | 728.58K | 2.74% | $6.76M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 11.52M | 0.00% | 3.46M |
State street | 3.92M | 0.00% | 1.52M |
Bank of america corp /de/ | 1.04M | 0.00% | 809.12K |
Raymond james financial | 884.38K | 0.00% | 520.14K |
Rosalind advisors | 1.13M | 4.93% | 243.70K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Braidwell lp | - | - | -2.24M |
Great point partners | - | - | -1.73M |
Blackrock funding, inc. /de | 10.55M | 0.00% | -1.47M |
Adage capital partners gp | 3.89M | 0.06% | -1.31M |
Perceptive advisors | - | - | -915.77K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Imc-chicago | 207.76K | 0.00% | 207.76K | $1.93M |
Weiss asset management lp | 187.62K | 0.02% | 187.62K | $1.74M |
Dark forest capital management lp | 161.90K | 0.06% | 161.90K | $1.50M |
Courier capital | 56.44K | 0.03% | 56.44K | $481.98K |
Hudson bay capital management lp | 54.09K | 0.00% | 54.09K | $501.95K |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Parallel advisors | -1.00 |
Nelson, van denburg & campbell wealth management group | -17.00 |
Stephens consulting | -50.00 |
Coldstream capital management | -70.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 192 | -4.48% | 156,898,610 | 16.16% | 90 | 1.43% | 96 | 3.23% | 47 | -20.34% |
Mar 31, 2025 | 202 | 8.60% | 137,366,906 | 2.63% | 81 | 1.26% | 93 | -1.06% | 60 | 57.89% |
Dec 31, 2024 | 177 | 2.31% | 128,615,765 | -8.11% | 77 | 1.10% | 89 | 14.10% | 36 | -21.74% |
Sep 30, 2024 | 172 | 13.91% | 139,954,059 | 2.07% | 83 | 0.78% | 79 | -13.19% | 46 | 70.37% |
Jun 30, 2024 | 151 | -0.66% | 137,118,555 | 10.64% | 103 | 1.18% | 91 | -14.95% | 27 | 17.39% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 7.46M | 4.68% | 5.14M |
Fidelity Growth Company Fund | 6.01M | 3.77% | 4.38M |
Vanguard US Total Market Shares ETF | 4.64M | 2.92% | - |
Vanguard Total Stock Mkt Idx Inv | 4.70M | 2.72% | -104.94K |
iShares Russell 2000 ETF | 3.32M | 1.92% | -63.10K |
Fidelity Small Cap Index | 1.60M | 1.01% | 1.16K |
Fidelity Series Growth Company | 1.55M | 0.97% | 1.10M |
Fidelity Growth Company K6 | 1.44M | 0.90% | 945.81K |
Fidelity Select Pharmaceuticals Port | 1.31M | 0.82% | 346.20K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.38M | 0.80% | -593.25K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 02, 2025 | Waheed Nadia | Chief Medical Officer | Sell | $111.58K |
May 23, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | $13.35K |
May 23, 2025 | Kaiser Peter | Chief Development Officer | Sell | $21.32K |
May 23, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell | $21.71K |
May 23, 2025 | Dugel Pravin | See Remarks | Sell | $152.35K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | 1 | 5 |
2025 Q1 | - | 6 |
2024 Q4 | - | 4 |
2024 Q3 | - | 2 |
OCUL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools